Orient Pharma (OP), focusing on R&D and manufacturing and established on Feb 1, 2008, is the subsidiary of Orient Europharma(OEP). Located in Yunlin county in the central of Taiwan, the plant was completely constructed in 2010 Q2. The Yunlin plant obtained the approval for PIC/S GMP from the Taiwan FDA in July, 2011. In addition, it received “Accreditation Certificate of Foreign Drug Manufacturer” from Japan Ministry of Health, Laboar, and Welfare (MHLW) in April, 2012. Furthermore, the Yunlin plant passed the cGMP site inspection by US FDA in April 2013.